MEDBOX | Category Leishmaniasis

Leishmaniasis

Advanced search

Create your MEDBOX

Leishmaniasis

Advanced search

Create your MEDBOX

Go back

OUR RECOMMENDATIONS

Post-Kala-Azar Dermal Leishmaniasis: A Manual for Case Management and Control (2013)

NEW

NEW

Guideline for the Treatment of Leishmaniasis in the Americas (2022)

WHO guideline for the treatment of visceral leishmaniasis in HIV co-infected patients in East Africa and South-East Asia (2022)

Target product profile for a point-of-care diagnostic test for dermal leishmaniases (2022)

Interactive Atlas of Leishmaniasis in the Americas: Clinical Aspects and Differential Diagnosis (2021)

LIST OPTIONS

FILTER BY LANGUAGE

FILTER BY COUNTRY

SORT BY

RESULTS/PAGE

LIST TYPE

8 records

	Guideline for the Treatment of Leishmaniasis in the Americas World Health Organization WHO (2022) C_WHO View PDF(0) Download (1) Add to my MEDBOX 2nd edition. These guidelines include several notable changes from the first edition. For cutaneous leishmaniasis, ketoconazole has been removed from the list of treatment options; the number of Leishmania species for which there is strong evidence for the efficacy of miltefosine has increased from two to four; and the recommendation for intralesional antimonials is now strong. For mucosal leishmaniasis there is now a strong recommendation for use of pentavalent antimonials with or without oral pentoxifylline. For visceral leishmaniasis, the strong recommendations for use of pentavalent antimonials and amphotericin B deoxycholate are now conditional Tags: Leishmaniasis, treatment, Guidelines, Americas, Source: https://iris.paho.org/bitstream/handle/1
	Manual de procedimientos para vigilancia y control de las leishmaniasis en las Américas Pan American Health Organization (PAHO) (2019) C_WHO View PDF(171) Download (151) Add to my MEDBOX Tags: Leishmaniasis, control policy, control programmes, control, Vector Control, guideline, guía, Leishmaniasis Cutánea, Vectores de Enfermedades, control de vectores, zoonosis, Source: http://iris.paho.org/xmlui/bitstream/han
	Post-Kala-Azar Dermal Leishmaniasis: A Manual for Case Management and Control World Health Organization WHO (2013) C_WHO View PDF(2468) Download (1265) Add to my MEDBOX Tags: Epidemiology, Treatment, Source: http://apps.who.int/iris/bitstream/10665
	Manual de diagnóstico y tratamiento. Leishmaniosis Ministerio de salud pública y bienestar social (2011) C1 View PDF(664) Download (1141) Add to my MEDBOX Tags: paraguay, leishmaniosis, diagnóstico, tratamiento, Source: https://www.mspbs.gov.py/dependencias/im
	Guía de atención de la leishmaniasis Echeverry, M. C. ; Gaona Narváez, J.; Gualtero Trujillo, S. M.; et al Ministerio de la Protección Social, Colombia (2005) C1 View PDF(40) Download (47) Add to my MEDBOX La leishmaniasis es un problema creciente de salud pública en el contextomundial. En Colombia, la situación es de alarma debido al incremento de casos de leishmaniasis cutánea que se viene registrando desde 2003 y el cambio en el patrón epidemiológico dado por la aparición de nuevos focos, el proceso cre-ciente de domiciliación y urbanización del ciclo de transmisión Tags: Leishmaniasis, enfermedades infecciosas, infectious diseases, Mosquitos, colombia, guía, Source: https://www.acin.org/images/guias/Guia_L
	Interactive Atlas of Leishmaniasis in the Americas: Clinical Aspects and Differential Diagnosis Pan American Health Organisation PAHO (2021) C_WHO View PDF(55) Download (68) Add to my MEDBOX In the Region of the Americas, the leishmaniases are a group of diseases caused by various species of Leishmania, which cause a set of clinical syndromes in infected humans that can involve the skin, mucosa, and visceral organs. The spectrum of clinical disease is varied and depends on the interaction of several factors related to the parasite, the vector, and the host. Cutaneous leishmaniasis is the form most frequently reported in the Region and nearly 90% of cases present single or multiple localized lesions. Other cutaneous clinical forms, such as disseminated and diffuse cutaneous leishmaniasis, are more difficult to treat and relapses are common. The mucosal form is serious because it can cause disfigurement and severe disability if not diagnosed and treated early on. Visceral leishmaniasis is the most severe form, as it can cause death in up to 90% of untreated people Tags: clinical aspects, Leishmaniasis, diagnosis, parasites, visceral leishmaniasis (VL), paho, skin disease, Communicable diseases, cutaneous leishmaniasis (CL), atlas, training resource, Source: https://iris.paho.org/handle/10665.2/531
	Target product profile for a point-of-care diagnostic test for dermal leishmaniases World Health Organization WHO (2022) C_WHO View PDF(6) Download (8) Add to my MEDBOX In 2007, the Sixtieth World Health Assembly adopted resolution WHA60.13 on control of leishmaniasis, urging Member States, among other actions: to strengthen prevention, active detection and treatment of cases of both cutaneous and visceral leishmaniasis in order to decrease the disease burden; and to strengthen the capacity of peripheral health centres to deliver primary and secondary care, so that they provide appropriate affordable diagnosis and treatment and act as sentinel surveillance sites Tags: diagnostics, cuteneous, visceral leishmaniasis (VL), Leishmaniasis, Point-of-Care-Testing, Source: https://apps.who.int/iris/rest/bitstream
	WHO guideline for the treatment of visceral leishmaniasis in HIV co-infected patients in East Africa and South-East Asia World Health Organization WHO (2022) C_WHO View PDF(4) Download (5) Add to my MEDBOX The leishmaniases are a group of diseases caused by Leishmania spp., which occur in cutaneous, mucocutaneous and visceral forms. They are neglected tropical diseases (NTDs), which disproportionately affect marginalized populations who have limited access to health care. HIV co-infected patients with Leishmania infection are highly infectious to sandflies, and an increase in the coinfection rate in an endemic area is likely to increase the effective infective reservoir Tags: visceral leishmaniasis (VL), hiv, opportunistic infections, South-East Asia, east africa, Source: https://apps.who.int/iris/rest/bitstream

8 records

8 records